Prognostic Factors and Survival in 481 Patients with Pancreatic and Peripancreatic Endocrine Tumors: Results from the National Cancer Registry of Spain (RGETNE)


Introduction: Duodenopancreatic neuroendocrine tumors (NETs) are uncommon neoplasms with a wide spectrum of clinical presentation. The infrequent occurrence of these tumors makes large experiences very scarce.

Aim(s): To present 483 NETs in the pancreas and peripancreatic region, comparing the clinical features and survival between functional and nonfunctional NETs.

Materials and methods: The study population was obtained from the National Cancer Registry for Gastroenteropancreatic Neuroendocrine Tumors (RGETNE) of Spain. From June 2001 through October 2010, 481 patients with NETs in the pancreas and peripancreatic region were prospectively registered. Prognostic factors were determined by univariate and multivariate analyses.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: Martin-Perez E, Capdevila J, Castellano D, Jiménez-Lacave A, Beguiristain-Gómez A,

Keywords: pancreatic neuroendocrine tumors, gastrinoma, glucagonoma, insulinoma, registry, survival, treatment,

To read the full abstract, please log into your ENETS Member account.